Aakash Desai, Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center, shared an article by Yixuan Liu, et al. on X:
“Interesting innovation in cancer therapy
Nature Communications reported a protease-cleavable liposome that co-delivers anti–PD-L1 and doxorubicin directly to tumors in mice.
- Tumor penetration
- Immune activation
- Targeted drug release”
A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice.
Authors: Yixuan Liu, et al.
More posts featuring Colon Cancer.
